MFS Transporter Variants for Higher Purine Nucleotide Fermentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing microorganisms have limited capacity for producing purine nucleotides such as 5'-xanthosine monophosphate (XMP) and 5'-guanosine monophosphate (GMP), necessitating improved production methods to meet increasing demand.
Innovation Solution
Introduction of an MFS transporter variant with specific amino acid substitutions at designated positions in the amino acid sequence, enhancing the purine nucleotide-producing ability of Corynebacterium microorganisms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If target substance-specific approaches are used to increase purine nucleotide production, then production efficiency is improved, but production capacity remains limited
Solution Approach 1:
The patent applies parameter changes by modifying amino acid residues at specific positions (185, 238, 259, 283, 310, 354, 378, 383, and 403) of the MFS transporter protein. These parameter changes at the molecular level alter the transporter's function to enhance purine nucleotide production capacity beyond what conventional gene expression modulation can achieve.
2Ease of manufacture
If conventional microorganisms are used for production, then process simplicity is maintained, but production ability is insufficient
Solution Approach 1:
The patent applies local quality by making specific localized modifications to the MFS transporter protein at defined amino acid positions while leaving the rest of the protein structure and the overall fermentation process unchanged. This allows enhanced production ability while maintaining process simplicity.
Data Source
AI summary
Provided are a microorganism producing a purine nucleotide and a method of producing a purine nucleotide using the same.


